Arrhythmic death in implantable cardioverter defibrillator patients: A long-term study over a 10 year implantation period

Europace

Volumn 11, Issue 11, 2009, Pages 1462-1468

  Duray, Gabor Z ^a   Schmitt, Joern ^a   Richter, Sergio ^a   Israel, Carsten W ^a   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Arrhythmogenic death; Implantable defibrillator; Mortality in ICD recipients; Sudden cardiac death

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOTALOL;

ADULT; AGING; ARRHYTHMOGENESIS; ARTICLE; CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; TREATMENT OUTCOME;

AGE DISTRIBUTION; AGED; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; GERMANY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 71049123912     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup246     Document Type: Article

References (23)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association. Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
2. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS et al. ACC/AHA/HRS2008 guidelines for device-based therapy of cardiac rhythm abnormalities:executive summary: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation 2008;117: 2820-2840
3. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: An urgent target for clinicians, industry and government. J Interv Card Electrophysiol 2005;14:71-78
4. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: The importance of postshock electromechanical dissociation. J Am Coll Cardiol 2002;39:1323-1328
5. Pires LA, Hull ML, Nino CL, May LM, Ganji JR. Sudden death in recipients of transvenous implantable cardioverter defibrillator systems: Terminal events, predictors, and potential mechanisms. J Cardiovasc Electrophysiol 1999;10:1049-1056
6. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-1465
7. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65:457-464
8. Cairns JA, Connolly SJ, Roberts R, Gent M Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-682
9. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C et al. ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-678
10. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302
11. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. Randomized trial of prophylactic implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488
12. Bigger JT Jr, Whang W, Rottman JN, Kleiger RE, Gottlieb CD, Namerow PB et al. Mechanisms of death in the CABG Patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999;99:1416-1421
13. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
14. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES et al. Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. J Am Med Assoc 2006;295:165-171
15. Hohnloser SH, Al-Khalidi HR, Pratt CM, Brum JM, Tatla DS, Tchou P et al. Shock Inhibition Evaluation with AzimiLiDe (SHIELD) Investigators. Electrical storm in patients with an implantable defibrillator: Incidence, features, and preventive therapy: Insights from a randomized trial. Eur Heart J 2006;27:3027-3032
16. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H et al. MADIT II Investigators. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 2009;6:468-473
17. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ et al. Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-490
18. Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD. Sudden death in implantable cardioverter-defibrillator recipients: Clinical context, arrhythmic events and device responses. J Am Coll Cardiol 1999;33:24-32.
19. Marijon E, Trinquart L, Otmani A, Waintraub X, Kacet S, Clémenty J et al. Evaluation Médico-Economique du Défibrillateur Automatique Implantable (EVADEF) Investigators. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study. Am Heart J 2009;157:391-397
20. Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ et al. for the MADIT-II Research Group. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation trial (MADIT)-II. J Am Coll Cardiol 2006;47:769-773
21. Dickinson MG, Ip JH, Olshansky B, Hellkamp AS, Anderson J, Poole JE et al. SCD-HeFT Investigators. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: Mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007;153:573-578
22. Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML et al. MADIT-II Research Group. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy. Heart Rhythm 2007;4:1395-1402
23. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-2665